ID   TRA-1-81
AC   CVCL_A1QT
SY   Tra-1-81; TRA-1-81 cl.26
DR   Wikidata; Q105511263
RX   PubMed=6396197;
RX   PubMed=21159783;
CC   Biotechnology: The monoclonal antibody produced by this hybridoma along with that produced by TRA-1-60 (Cellosaurus=CVCL_A1QS) are widely used in human stem cell research as positive indicators of a true pluripotent human stem cell.
CC   Monoclonal antibody isotype: IgM.
CC   Monoclonal antibody target: Type 1 lactosamine minimal epitope Galbeta1-3GlcNAcbeta1-3Galbeta1-4GlcNAc (Note=Recognizes human podocalyxin).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 12-01-21; Last updated: 21-03-23; Version: 5
//
RX   PubMed=6396197; DOI=10.1089/hyb.1984.3.347;
RA   Andrews P.W., Banting G.S., Damjanov I., Arnaud D., Avner P.;
RT   "Three monoclonal antibodies defining distinct differentiation
RT   antigens associated with different high molecular weight polypeptides
RT   on the surface of human embryonal carcinoma cells.";
RL   Hybridoma 3:347-361(1984).
//
RX   PubMed=21159783; DOI=10.1093/glycob/cwq209;
RA   Natunen S., Satomaa T., Pitkanen V., Salo H., Mikkola M., Natunen J.,
RA   Otonkoski T., Valmu L.;
RT   "The binding specificity of the marker antibodies Tra-1-60 and
RT   Tra-1-81 reveals a novel pluripotency-associated type 1 lactosamine
RT   epitope.";
RL   Glycobiology 21:1125-1130(2011).
//